Related Experiment Video
Updated: May 13, 2026
06:15
Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
Published on: October 27, 2014
Targeted Bevacizumab Therapy for Recurrent Vocal Fold Hemorrhage: First Case Report
Andrés Lanas Volz1, Camila Ramírez Pelayo1
1Department of Otolaryngology, Clínica Universidad de Los Andes, Santiago, Chile.
The Laryngoscope
|May 12, 2026
Abstract
None:
This case report describes the use of targeted intracordal bevacizumab therapy for recurrent vocal fold hemorrhage refractory to conventional treatment. The intervention was associated with resolution of hemorrhagic episodes and sustained clinical improvement over follow-up. These findings suggest a potential role for antiangiogenic therapy in selected cases.